Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.500
0.00 (0.00%)
May 7, 2026, 3:43 PM HKT

HKG:2563 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
28.6571.8766.6432.8271.06
Other Revenue
4.72----
33.3671.8766.6432.8271.06
Revenue Growth (YoY)
-53.57%7.85%103.03%-53.82%-
Cost of Revenue
2.6210.7819.818.944.17
Gross Profit
30.7461.0946.8323.8866.89
Selling, General & Admin
65.61114.27139.3149.41267.37
Research & Development
82.99116.29126.5482.7491.97
Other Operating Expenses
-0.51-1.66-1.25-15.250.96
Operating Expenses
168.74229.19263.3218.11360.69
Operating Income
-138-168.1-216.47-194.23-293.79
Interest Expense
-0.05-0.06-0.06-0.07-0.07
Interest & Investment Income
16.3415.6213.143.3414.11
Currency Exchange Gain (Loss)
-10.185.544.6519.6-4.9
Other Non Operating Income (Expenses)
2.86----0.03
EBT Excluding Unusual Items
-129.03-146.99-198.74-171.36-284.68
Gain (Loss) on Sale of Investments
-0.053.229.110.858.46
Asset Writedown
-2.36----
Other Unusual Items
-----1.92
Pretax Income
-131.44-143.78-189.64-160.51-278.14
Net Income
-131.44-143.78-189.64-160.51-278.14
Net Income to Common
-131.44-143.78-189.64-160.51-278.14
Shares Outstanding (Basic)
365352350350350
Shares Outstanding (Diluted)
365352350350350
Shares Change (YoY)
3.58%0.71%---
EPS (Basic)
-0.36-0.41-0.54-0.46-0.79
EPS (Diluted)
-0.36-0.41-0.54-0.46-0.79
Free Cash Flow
--143.52-178.62-111.3-89.83
Free Cash Flow Per Share
--0.41-0.51-0.32-0.26
Gross Margin
92.13%85.00%70.27%72.76%94.13%
Operating Margin
-413.63%-233.91%-324.87%-591.81%-413.42%
Profit Margin
-393.94%-200.06%-284.60%-489.06%-391.40%
Free Cash Flow Margin
--199.71%-268.05%-339.12%-126.41%
EBITDA
-130.14-160.24-207.3-185.14-286.11
EBITDA Margin
--222.97%---
D&A For EBITDA
7.867.869.179.17.69
EBIT
-138-168.1-216.47-194.23-293.79
EBIT Margin
--233.91%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.